This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Monami, G. Articles by Morrione, A. Search for Related Content PubMed PubMed Citation Articles by Monami, G. Articles by Morrione, A.

Proepithelin Promotes Migration and Invasion of 5637 Bladder Cancer Cells through the Activation of ERK1/2 and the Formation of a Paxillin/FAK/ERK Complex

Departments of ¹ Urology and ² Pathology, Anatomy and Cell Biology and ³ Cellular Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania

Requests for reprints: Andrea Morrione, Department of Urology, Cellular Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, BLSB Room 631, 233 South 10th Street, Philadelphia, PA 19107. Phone: 215-503-4519; Fax: 215-923-0249; E-mail: Andrea.Morrione{at}jefferson.edu or amorrion{at}mail.jci.tju.edu.

The growth factor proepithelin (also known as progranulin, acrogranin, PC-derived growth factor, or granulin-epithelin precursor) is a secreted glycoprotein that functions as an important regulator of cell growth, migration, and transformation. Proepithelin is overexpressed in a great variety of cancer cell lines and clinical specimens of breast, ovarian, and renal cancer as well as glioblastomas. In this study, we have investigated the effects of proepithelin on bladder cancer cells using human recombinant proepithelin purified to homogeneity from 293-EBNA cells. Although proepithelin did not appreciably affect cell growth, it did promote migration of 5637 bladder cancer cells and stimulate in vitro wound closure and invasion. These effects required the activation of the mitogen-activated protein kinase pathway and paxillin, which upon proepithelin stimulation formed a complex with focal adhesion kinase and active extracellular signal-regulated kinase. Our results provide the first evidence for a role of proepithelin in stimulating migration and invasion of bladder cancer cells, and support the hypothesis that this growth factor may play a critical role in the establishment of the invasive phenotype. (Cancer Res 2006; 66(14): 7103-10)

This article has been cited by other articles:

				F. Lovat, A. Bitto, S.-Q. Xu, M. Fassan, S. Goldoni, D. Metalli, V. Wubah, P. McCue, G. Serrero, L. G. Gomella, et al. Proepithelin is an autocrine growth factor for bladder cancer Carcinogenesis, May 1, 2009; 30(5): 861 - 868. [Abstract] [Full Text] [PDF]

				G. Monami, V. Emiliozzi, A. Bitto, F. Lovat, S.-Q. Xu, S. Goldoni, M. Fassan, G. Serrero, L. G. Gomella, R. Baffa, et al. Proepithelin Regulates Prostate Cancer Cell Biology by Promoting Cell Growth, Migration, and Anchorage-Independent Growth Am. J. Pathol., March 1, 2009; 174(3): 1037 - 1047. [Abstract] [Full Text] [PDF]

				C. K. Sun, K. Man, K. T. Ng, J. W. Ho, Z. X. Lim, Q. Cheng, C.-M. Lo, R. T. Poon, and S.-T. Fan Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation Carcinogenesis, November 1, 2008; 29(11): 2096 - 2105. [Abstract] [Full Text] [PDF]

				S. N. Hamadmad and R. J. Hohl Erythropoietin Stimulates Cancer Cell Migration and Activates RhoA Protein through a Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase-Dependent Mechanism J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1227 - 1233. [Abstract] [Full Text] [PDF]